Home About Cytheris Corporate Overview Executive Management Board of Directors Clinical Advisory Board Academic Partners History Science Portfolio Overview Interleukin-7 NKT Ligands Pipeline & Products Development Pipeline IL-7 in Oncology IL-7 in HIV IL-7 in HCV NKT Ligands Intellectual Property Manufacturing Clinical Trials Clinical Trials Overview IL-7 Oncology Trials IL-7 HIV Trials IL-7 HCV Trials Other IL-7 Trials Business Development News Room Press Releases Calendar of Events Investors Careers Contact Us

Press Releases 2007
November 26, 2007
	Cytheris Appoints Richard Keatinge as Chief Business Officer
	FR
September 26, 2007
	Cytheris Expands Interleukin-7 Clinical Development Program with International Phase I/IIa Trial in HIV
	FR
May 31, 2007
	Cytheris to Start Two Phase I/IIa Clinical Trials of CYT107, Its New Recombinant Interleukin-7, in Hepatitis C and Oncology
	FR
April 2, 2007
	Cytheris Names CFO and CMO as Company Boosts Clinical Development Program in Europe and the US
	FR
March 5, 2007
	Cytheris Releases Promising Clinical Data on its Interleukin-7 Immune Enhancer at the 2007 CROI Meeting in Los Angeles
	FR